L. Dans-tous and . Cas, les manifestations cliniques de ces maladies étant proches, leur diagnostic ainsi que les traitements pris par le patient devront être connus afin d

F. Guillemin, A. Saraux, P. Guggenbuhl, C. Roux, P. Fardellone et al., Prevalence of rheumatoid arthritis in France: 2001, Annals of the Rheumatic Diseases, vol.64, issue.10, pp.1427-1457, 2001.
DOI : 10.1136/ard.2004.029199

J. Roudier, N. Balandraud, B. Mugnier, S. Guis, D. Reviron et al., R??le des mol??cules HLA-DR dans le d??veloppement de la polyarthrite rhumato??de, Revue du Rhumatisme, vol.72, issue.4, pp.287-296, 2005.
DOI : 10.1016/j.rhum.2005.01.005

P. Gregersen, J. Silver, and R. Winchester, The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis & Rheumatism, vol.4, issue.11, pp.1205-1213, 1997.
DOI : 10.1007/978-3-642-69770-8_99

D. Reviron, A. Perdriger, E. Toussirot, D. Wendling, N. Balandraud et al., Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis, Arthritis & Rheumatism, vol.42, issue.3, pp.535-575, 2001.
DOI : 10.1002/1529-0131(200103)44:3<535::AID-ANR101>3.0.CO;2-Z

F. Brennan, R. Maini, and M. Feldmann, Role of pro-inflammatory cytokines in rheumatoid arthritis, Springer Seminars in Immunopathology, vol.40, issue.1-2, pp.133-180, 1998.
DOI : 10.1007/BF00832003

S. Tanaka, Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways, World Journal of Orthopedics, vol.4, issue.1, p.1, 2013.
DOI : 10.5312/wjo.v4.i1.1

J. Anderson, G. Wells, A. Verhoeven, and D. Felson, Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration, Arthritis & Rheumatism, vol.4, issue.1, pp.22-31, 2000.
DOI : 10.1001/jama.1949.02900430001001

H. Visser, Early diagnosis of rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, vol.19, issue.1, pp.55-72, 2005.
DOI : 10.1016/j.berh.2004.08.005

B. Combe, C. Lukas, and J. Morel, Polyarthrite rhumatoïde de l'adulte : épidémiologie, clinique et diagnostic. EMC -Appareil locomoteur, pp.1-16, 2015.
DOI : 10.1016/s0246-0521(07)43710-x

C. Gaujoux-viala, L. Gossec, A. Cantagrel, M. Dougados, B. Fautrel et al., Recommandations de la Soci??t?? fran??aise de rhumatologie pour la prise en charge de la polyarthrite rhumato??de, Revue du Rhumatisme, vol.81, issue.4, pp.303-315, 2014.
DOI : 10.1016/j.rhum.2014.04.009

URL : http://doi.org/10.1016/j.rhum.2014.04.009

J. Morel and B. Combe, How to predict prognosis in early rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, vol.19, issue.1, pp.137-183, 2005.
DOI : 10.1016/j.berh.2004.08.008

K. Forslind, M. Ahlmen, K. Eberhardt, I. Hafstrom, and B. Svensson, Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP), Annals of the Rheumatic Diseases, vol.63, issue.9, pp.1090-1095, 2004.
DOI : 10.1136/ard.2003.014233

F. Mcqueen, Imaging in early rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, vol.27, issue.4, pp.499-522, 2013.
DOI : 10.1016/j.berh.2013.09.005

M. Prete, V. Racanelli, L. Digiglio, A. Vacca, F. Dammacco et al., Extra-articular manifestations of rheumatoid arthritis: An update, Autoimmunity Reviews, vol.11, issue.2, pp.123-154, 2011.
DOI : 10.1016/j.autrev.2011.09.001

C. Lukas, B. Combe, P. Ravaud, J. Sibilia, R. Landew et al., Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the Study and Followup of Early Undifferentiate Arthritis Rheum, pp.1804-1815, 2011.

L. Caplan, F. Wolfe, A. Russell, and K. Michaud, Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes, J Rheumatol, vol.34, issue.4, pp.696-705, 2007.

M. Lopez-olivo, H. Siddhanamatha, B. Shea, P. Tugwell, G. Wells et al., Methotrexate for treating rheumatoid arthritis, 2014.
DOI : 10.1016/0002-9343(85)90312-2

K. Visser and D. Van-der-heijde, Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature, Annals of the Rheumatic Diseases, vol.68, issue.7, pp.1094-1103, 2009.
DOI : 10.1136/ard.2008.092668

J. Smolen, R. Landewé, F. Breedveld, M. Buch, G. Burmester et al., EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update, Annals of the Rheumatic Diseases, vol.69, issue.(Suppl), pp.492-509, 2014.
DOI : 10.1136/ard.2009.108472

M. Hetland, M. Østergaard, B. Ejbjerg, S. Jacobsen, K. Stengaard-pedersen et al., Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP, Annals of the Rheumatic Diseases, vol.71, issue.6, pp.851-857, 2012.
DOI : 10.1136/annrheumdis-2011-200632

R. Forestier, J. André-vert, P. Guillez, E. Coudeyre, M. Lefevre-colau et al., Polyarthrite rhumatoïde, aspects thérapeutiques hors médicament et chirurgie ? aspects médicosociaux et organisationnels
DOI : 10.1016/s1779-0123(12)75286-5

M. Østensen and P. Villiger, The remission of rheumatoid arthritis during pregnancy, Seminars in Immunopathology, vol.110, issue.Suppl 107
DOI : 10.1111/j.1600-0897.1997.tb00307.x

N. Pischon, T. Pischon, J. Kröger, E. Gülmez, B. Kleber et al., Association Among Rheumatoid Arthritis, Oral Hygiene, and Periodontitis, Journal of Periodontology, vol.79, issue.6, pp.979-86, 2008.
DOI : 10.1902/jop.2008.070501

I. Smolik, D. Robinson, and H. El-gabalawy, Periodontitis and Rheumatoid Arthritis: Epidemiologic, Clinical, and Immunologic Associations, Compend Contin Educ Dent, vol.30, issue.4, pp.188-98, 2009.

P. Pablo, T. Dietrich, and T. Mcalindon, Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population, J Rheumatol, vol.35, issue.1, pp.70-76, 2008.

J. Stein, S. Reichert, A. Gautsch, and H. Machulla, Are there HLA combinations typical supporting for or making resistant against aggressive and/or chronic periodontitis?, Journal of Periodontal Research, vol.38, issue.5, pp.508-525, 2003.
DOI : 10.1034/j.1600-0765.2003.00683.x

J. J. Bonfil, F. L. Dillier, P. Mercier, D. Reviron, B. Foti et al., A "case control" study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identification of types and subtypes using molecular biology (PCR.SSO), Journal of Clinical Periodontology, vol.26, issue.2, p.77, 1999.
DOI : 10.1034/j.1600-051X.1999.260203.x

H. Marotte, The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction, Annals of the Rheumatic Diseases, vol.65, issue.7, pp.905-914, 2005.
DOI : 10.1136/ard.2005.036913

URL : https://hal.archives-ouvertes.fr/hal-00400095

F. Mercado, R. Marshall, A. Klestov, and P. Bartold, Relationship Between Rheumatoid Arthritis and Periodontitis, Journal of Periodontology, vol.72, issue.6, pp.779-87, 2001.
DOI : 10.1902/jop.2001.72.6.779

N. Bostanci, T. ?lgenli, G. Emingil, B. Afacan, B. Han et al., Differential expression of receptor activator of nuclear factor-?B ligand and osteoprotegerin mRNA in periodontal diseases, Journal of Periodontal Research, vol.128, issue.4, pp.287-93, 2007.
DOI : 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#

A. Van-winkelhoff, B. Loos, W. Van-der-reijden, and U. Van-der-velden, Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction, Journal of Clinical Periodontology, vol.24, issue.20, pp.1023-1031, 2002.
DOI : 10.1034/j.1600-051X.2002.291107.x

R. Martinez-martinez, C. Abud-mendoza, N. Patiño-marin, J. Rizo-rodríguez, J. Little et al., Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients, Journal of Clinical Periodontology, vol.66, issue.12, pp.1004-1014, 2009.
DOI : 10.1902/jop.2006.050177

M. Underner, I. Maes, T. Urban, and J. Meurice, Effets du tabac sur la maladie parodontale, Revue des Maladies Respiratoires, vol.26, issue.10, pp.1057-73, 2009.
DOI : 10.1016/S0761-8425(09)73533-8

A. Al-suwyed, Benefits of Periodontal Therapy on Rheumatoid Arthritis, Biol Ther Dent, vol.28, issue.1, pp.2-3, 2012.

M. Leech and P. Bartold, The association between rheumatoid arthritis and periodontitis, Best Practice & Research Clinical Rheumatology, vol.29, issue.2, pp.189-201, 2015.
DOI : 10.1016/j.berh.2015.03.001

M. Vis, E. Havaardsholm, G. Haugeberg, T. Uhlig, A. Voskuyl et al., Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NF??B ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.65, issue.11, pp.1495-1504, 2006.
DOI : 10.1136/ard.2005.044198

K. Ahola, A. Saarinen, A. Kuuliala, M. Leirisalo-repo, H. Murtomaa et al., Impact of rheumatic diseases on oral health and quality of life, Oral Diseases, vol.43, issue.3, pp.342-350, 2015.
DOI : 10.3109/07853890.2011.595734

Y. Keri?, E. Yaman, S. Demira?, M. Haznedaro?lu, and ?. , Temporomandibular joint findings in patients with rheumatoid arthritis, ankylosing spondylitis, and primary Sjögren's syndrome, J Investig Clin Dent, 2016.

H. Marotte, Les articulations temporomandibulaires et les pathologies rhumatismales inflammatoires Revue de Stomatologie, de Chirurgie Maxillo-faciale et de Chirurgie Orale, pp.223-230, 2016.
DOI : 10.1016/j.revsto.2016.07.011

K. Abdelghani, I. Mahmoud, E. Chatelus, C. Sordet, J. Gottenberg et al., Clinical and Serological Features of Sjogren Syndrome in Patients with Rheumatoid Arthritis, British Journal of Medicine and Medical Research, vol.5, issue.10, pp.1287-93, 2014.
DOI : 10.9734/BJMMR/2015/13688

R. Dugal and . Xerostomia, Dental Implications and Management, Ann Essences Dent, vol.2, issue.3, pp.137-177, 2010.

S. González, H. Sung, D. Sepúlveda, M. González, and C. Molina, Oral manifestations and their treatment in Sj??gren???s syndrome, Oral Diseases, vol.159, issue.Suppl, pp.153-61, 2014.
DOI : 10.1001/archinte.159.2.174

D. Ph, D. Durand, L. Jeune, and C. , Guide pratique des médicaments. Editions Maloine

A. Stuck, C. Minder, and F. Frey, Risk of Infectious Complications in Patients Taking Glucocorticosteroids, Clinical Infectious Diseases, vol.11, issue.6, pp.954-63, 1989.
DOI : 10.1093/clinids/11.6.954

J. Little, D. Falace, C. Miller, and N. Rhodus, Dental management of the medically compromised patient, pp.236-246, 2008.

J. Curtis, F. Xie, D. Mackey, N. Gerber, A. Bharat et al., Patient???s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis, BMC Musculoskeletal Disorders, vol.20, issue.4-a, 2016.
DOI : 10.2165/00063030-199708030-00002

G. Deeming, J. Collingwood, and M. Pemberton, Methotrexate and oral ulceration, British Dental Journal, vol.121, issue.2, pp.83-88, 2005.
DOI : 10.7326/0003-4819-121-11-199412010-00002

T. Pham, . Claudepierre, X. Deprez, B. Fautrel, P. Goupille et al., Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et inflammations (DRI), section of the French Society of Rheumatology (SFR), Joint Bone Spine, vol.72, pp.5-58, 2005.
DOI : 10.1016/s1297-319x(11)70001-x

H. Hassikou, M. Haouri, . El, F. Tabache, M. Baaj et al., Syndrome de Lyell au cours d???une polyarthrite rhumato??de trait??e par l??flunomide, Revue du Rhumatisme, vol.75, issue.9, pp.871-875, 2008.
DOI : 10.1016/j.rhum.2007.08.016

. Société-française-de-chirurgie-orale, Prise en charge des foyers infectieux buccodentaires (Recommandations), pp.30-33, 2012.